Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio" or the "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory ...

MELANIE Sykes has revealed she is battling alopecia and heart issues in a candid post about her health. TV presenter Mel, 54, ...

Elizabeth Sevigny reached rock bottom when her hair started to fall out, but everything changed when she had a baby and ...

According to market estimates, Leqselvi is projected to contribute $90 million to Sun Pharma's sales in FY26, and $125 ...

Indian drugmaker Sun (BSE: 524715) shares were buzzing in trade on the last trading day of the week to April 11, rising as ...

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

The US Court of Appeals for the Federal Circuit vacated a preliminary injunction on Leqselvi’s launch, lifting restrictions on the launch on April 9, Sun Pharma said in a regulatory filing.

Hair fall is a growing concern among men worldwide, impacting appearance and confidence. Hormonal imbalances, particularly ...

Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...

She took me to a dermatologist who prescribed steroid injections. That was the first time I heard the words, "Alopecia areata." I was 12, but, back then, it felt manageable—I could easily hide ...

Arcutis Biotherapeutics, Inc.’s ARQT share price has surged by 5.09%, which has investors questioning if this is right time to sell.

Hair is more than a style statement; it’s a mirror of our health. For both men and women, hair-related challenges – ranging ...